Improving the Treatment for Women With Early Stage Cancer of the Uterus (feMMe)
A Phase II Randomised Clinical Trial of Mirena® ± Metformin ± Weight Loss Intervention in Patients With Early Stage Cancer of the Endometrium
Sponsor: Queensland Centre for Gynaecological Cancer
This PHASE2 trial investigates Complex Endometrial Hyperplasia With Atypia and Grade 1 Endometrial Endometrioid Adenocarcinoma and is currently ongoing. Queensland Centre for Gynaecological Cancer leads this study, which shows 11 recorded versions since 2012 — indicating substantial longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.
Status Flow
Change History
11 versions recorded-
Sep 2024 — Present [monthly]
Active Not Recruiting PHASE2
-
Jul 2024 — Sep 2024 [monthly]
Active Not Recruiting PHASE2
-
May 2023 — Jul 2024 [monthly]
Active Not Recruiting PHASE2
Status: Unknown Status → Active Not Recruiting
-
Apr 2022 — May 2023 [monthly]
Unknown Status PHASE2
Status: Active Not Recruiting → Unknown Status
-
Apr 2021 — Apr 2022 [monthly]
Active Not Recruiting PHASE2
▶ Show 6 earlier versions
-
Jan 2021 — Apr 2021 [monthly]
Active Not Recruiting PHASE2
-
Apr 2020 — Jan 2021 [monthly]
Active Not Recruiting PHASE2
Status: Recruiting → Active Not Recruiting
-
Sep 2019 — Apr 2020 [monthly]
Recruiting PHASE2
-
Jun 2018 — Sep 2019 [monthly]
Recruiting PHASE2
-
May 2018 — Jun 2018 [monthly]
Recruiting PHASE2
-
Jan 2017 — May 2018 [monthly]
Recruiting PHASE2
First recorded
Dec 2012
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Queensland Centre for Gynaecological Cancer
- Queensland University of Technology
- The University of Queensland
For direct contact, visit the study record on ClinicalTrials.gov .